Examining effective monotherapy hypothesis for TB therapy failure and resistance emergence
The International Journal of Tuberculosis and Lung Disease · 2024
DOI: 10.5588/ijtld.24.0121 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2024. Verfasst von S Srivastava und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Texas at Tyler School of Medicine, Tyler, TX, USA;, Department of Cellular and Molecular Biology, University of…. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Isoniazid, Rifampin. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
BACKGROUND
We tested the hypothesis that because of the different metabolic states of Mycobacterium tuberculosis (Mtb) in lesions, drugs in combination therapy often act effectively as monotherapy, leading to therapy failure and resistance emergence.
METHODS
Bactericidal and sterilizing activity studies were performed in the hollow fiber system of TB (HFS-TB) using the human equivalent dose of isoniazid (INH) 300 mg/day, rifampin (RIF) 600 mg/day, and pyrazinamide (PZA) 1.5 g/day either as monotherapy, two-, and three-drug combination for 28 days. The Mtb population (log 10 CFU/ml) for each drug, either monotherapy or combination, was compared using an analysis of variance.
RESULTS
In the bactericidal activity studies, the microbial kill was driven by INH, followed by RIF, and PZA monotherapy failed. During the sterilizing activity, INH and RIF displayed similar microbial kill. The INH + RIF and RIF + PZA combinations were significantly different from each other but not from the INH + RIF + PZA combination. RIF and INH-resistant subpopulations did not increase despite premixing the inoculum with isogenic-resistant strains.
CONCLUSION
Effective monotherapy arising from the selectivity of antibiotics against special Mtb sub-populations may not be the primary mechanism of resistance emergence. Different metabolic populations of Mtb were killed by more than one drug and were not under monotherapy when combination therapy was administered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Texas at Tyler School of Medicine, Tyler, TX, USA;, Department of Cellular and Molecular Biology, University of Texas Health Science Centre at Tyler, Tyler, TX, USA.
- Mathematical Modeling and AI, Praedicare Inc, Dallas, TX, USA;, Hollow Fiber System & Experimental Therapeutics Laboratories, Praedicare Inc, Dallas, TX, USA.
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
Zitieren
APA
Srivastava, S., & Gumbo, T. (2024). Examining effective monotherapy hypothesis for TB therapy failure and resistance emergence. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.24.0121
Vancouver
Srivastava S, Gumbo T. Examining effective monotherapy hypothesis for TB therapy failure and resistance emergence. The International Journal of Tuberculosis and Lung Disease. 2024. doi:10.5588/ijtld.24.0121
BibTeX
@article{Srivastava2024,
author = {Srivastava, S and Gumbo, T},
title = {Examining effective monotherapy hypothesis for TB therapy failure and resistance emergence},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2024},
doi = {10.5588/ijtld.24.0121}
}
EUVIMED